Pavmed INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

27 Mar 2026

PAVM

10-K: PAVmed Navigates Financial Headwinds, Strategic Shifts

PAVmed Inc. reports significant financial restructuring, including a reverse stock split and capital raises, while advancing its medical device and diagnostics portfolio amidst ongoing operating losses.

NASDAQ

24 Mar 2025

PAVM

Pavmed INC

10-K: PAVmed Inc. Reports Financial Results for Fiscal Year 2024, Navigates Nasdaq Compliance and Strategic Realignment

PAVmed Inc. details its financial performance for 2024, highlights strategic initiatives including Lucid Diagnostics' deconsolidation, and addresses Nasdaq compliance while focusing on Veris Health and its incubator program.

NASDAQ

25 Mar 2024

PAVM

Pavmed INC

10-K: PAVmed Inc. Details Share Structure, Warrants, and Anti-Takeover Measures in 10-K Filing

PAVmed Inc.'s 10-K filing outlines its capital structure, including common stock, warrants, preferred stock, and convertible notes, as well as anti-takeover provisions.